Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer in a late-breaking oral presentation at the ASCO 2025 (American Society of Clinical Oncology)...
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile. This press release features multimedia. View the full release here: https://www.businesswi...
Starfall Education Foundation, a publicly supported nonprofit, has filed a lawsuit in Denver federal court today against Tencent Holdings Ltd (TCEHY), a Chinese technology conglomerate designated by the Pentagon as an agent of the Chinese military, and it's Singaporean subsidiaries, Level Infinite Pte Ltd and Proxima Beta Pte Ltd. (collectively “Tencent”), alleging that they hijacked Starfall’s U.S. trademarks to attract children to violent computer games and collect children's personal private...
Veracode, a global leader in application risk management, today released its Public Sector State of Software Security 2025 report, revealing alarming trends in software security across government organizations. Drawing from an extensive analysis of 1.3 million unique applications and 126.4 million raw findings, the research shows 78 percent of public sector organizations are operating with significant security debt—flaws left unaddressed for more than a year. Moreover, 55 percent are burdened w...
In a significant showcase for investors, BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its industry-leading oncology pipeline during today’s investor R&D Day. The event comes at a pivotal moment for the Company, which has more than 40 clinical and commercial stage assets in development, a signal of both scale and ambition. “At BeOne, our mission is simple yet bold: to create the world’s first next-generation on...
Mercans, a global leader in payroll technology, today announced three significant developments aimed at strengthening its service offerings and enhancing client experiences: the establishment of a Payroll Compliance Center of Excellence (CoE), the integration of HiBob into its technology ecosystem, and the launch of an AI-powered Digital Sales Room (DSR). Establishment of Payroll Compliance Center of Excellence In response to the increasing complexity of global payroll regulations, Mercans ...
Suzano, the world’s largest pulp producer, announces its first quarter results for 2025 (1Q25) with record net revenue of R$11.6 billion, up 22% on the same quarter last year (1Q24). The result was driven by the exchange rates, increased pulp sales volumes from the new Ribas do Rio Pardo mill, higher paper volume and prices and the positive contribution from our paperboard mills recently acquired in the U.S. The record revenues occurred despite a series of planned downtimes in the quarter, inc...
SWARM Biotactics, developer of bio-robotic systems based on fully controllable living insects for mission-critical operations, has secured €10 million in seed funding, bringing its total raised to €13 million, including a €3 million pre-seed. The round was backed by a consortium of international investors from Europe, the United States, and Australia, including Vertex Ventures US, Possible Ventures, and Capnamic, who was the first investor in the pre-seed round. Several early backers also incre...
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category le...